SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103. A total of 116 filers reported holding SYNAGEVA BIOPHARMA CORP in Q1 2014. The put-call ratio across all filers is 2.05 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $19,660,000 | +3.2% | 201,582 | -1.8% | 0.01% | 0.0% |
Q4 2014 | $19,046,000 | +45.3% | 205,265 | +7.7% | 0.01% | +42.9% |
Q3 2014 | $13,108,000 | -72.5% | 190,589 | -58.1% | 0.01% | -46.2% |
Q2 2014 | $47,622,000 | +152.6% | 454,402 | +100.0% | 0.01% | +18.2% |
Q1 2014 | $18,851,000 | +51.5% | 227,201 | +18.2% | 0.01% | +57.1% |
Q4 2013 | $12,439,000 | +2.2% | 192,201 | 0.0% | 0.01% | 0.0% |
Q3 2013 | $12,168,000 | +176.2% | 192,201 | +83.3% | 0.01% | +133.3% |
Q2 2013 | $4,405,000 | – | 104,880 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 10,660,432 | $1,117,213,000 | 13.68% |
BB BIOTECH AG | 898,476 | $94,160,000 | 4.47% |
SECTORAL ASSET MANAGEMENT INC | 516,445 | $54,123,000 | 2.29% |
Ghost Tree Capital, LLC | 30,000 | $3,144,000 | 2.22% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 3,521,000 | $369,001,000 | 1.48% |
Pier Capital, LLC | 83,493 | $8,750,000 | 1.24% |
ArrowMark Colorado Holdings LLC | 197,613 | $20,710,000 | 0.59% |
PALISADE CAPITAL MANAGEMENT, LP | 120,779 | $12,658,000 | 0.31% |
FORTALEZA ASSET MANAGEMENT INC/ | 5,440 | $570,000 | 0.26% |
Tradeworx Inc. | 2,936 | $308,000 | 0.25% |